{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:57:00Z","timestamp":1773205020167,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03712"],"award-info":[{"award-number":["20H03712"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.leukres.2025.108112","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T06:24:56Z","timestamp":1758695096000},"page":"108112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genes with altered expression by 5-Aza treatment in myeloid leukemia cells through methylation in intron 1"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-8273","authenticated-orcid":false,"given":"Machiko","family":"Fujioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-3623","authenticated-orcid":false,"given":"Hidehiro","family":"Itonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-7565","authenticated-orcid":false,"given":"Uladzislau","family":"Korzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-3863","authenticated-orcid":false,"given":"Akira","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-5780","authenticated-orcid":false,"given":"Koh-ichiro","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2009.11.020","article-title":"DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia","volume":"17","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.leukres.2025.108112_bib2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/leu.2014.15","article-title":"Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B","volume":"28","author":"Itonaga","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2025.108112_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/2159-8290.CD-16-1032","article-title":"Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers","volume":"7","author":"Glass","year":"2017","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.leukres.2025.108112_bib4","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/bjh.19392","article-title":"DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: a multicentre retrospective study","volume":"204","author":"Noguera-Castells","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2025.108112_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12185-016-1957-7","article-title":"DNA methylation in normal and malignant hematopoiesis","volume":"103","author":"Celik","year":"2016","journal-title":"Int J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2025.108112_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomized, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol."},{"issue":"15","key":"10.1016\/j.leukres.2025.108112_bib7","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"L\u00fcbbert","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2025.108112_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","article-title":"Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia","volume":"28","author":"Fenaux","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2025.108112_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18632\/oncotarget.481","article-title":"BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients","volume":"3","author":"Cluzeau","year":"2012","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.leukres.2025.108112_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2024.04.004","article-title":"Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers","volume":"42","author":"Diepstraten","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.leukres.2025.108112_bib11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/2159-8290.CD-22-0939","article-title":"Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to Azacitidine\/Venetoclax","volume":"13","author":"Waclawiczek","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-023-01505-w","article-title":"LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome","volume":"15","author":"Kaastrup","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.leukres.2025.108112_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2017.01.021","article-title":"CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression","volume":"168","author":"Spencer","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.leukres.2025.108112_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/2643-3230.BCD-20-0029","article-title":"TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia","volume":"2","author":"Yun","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"10","key":"10.1016\/j.leukres.2025.108112_bib15","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1038\/s41375-022-01659-1","article-title":"SLIT2 promoter hypermethylation-mediated SLIT2-IT1\/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm","volume":"36","author":"Zhang","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2025.108112_bib16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2025.108112_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-biochem-060614-034242","article-title":"Regulation of alternative splicing through coupling with transcription and chromatin structure","volume":"84","author":"Naftelberg","year":"2015","journal-title":"Annu Rev. Biochem"},{"issue":"37","key":"10.1016\/j.leukres.2025.108112_bib18","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/sj.onc.1204668","article-title":"Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences","volume":"20","author":"Lu","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/gcc.10248","article-title":"Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies","volume":"38","author":"Nagai","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085025","article-title":"Eicosapentaenoic acid activates RAS\/ERK\/C\/EBP\u03b2 pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells","volume":"9","author":"Ceccarelli","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.leukres.2025.108112_bib21","first-page":"2356","article-title":"Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in wilms' tumor","volume":"60","author":"Malik","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib22","first-page":"429","article-title":"Fgfr4 is required for effective muscle regeneration in vivo","volume":"281","author":"Zhao","year":"2006","journal-title":"Delin. a MyoDTead2Fgfr4 Transcr. Pathw. J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.leukres.2025.108112_bib23","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/nar\/gkm271","article-title":"Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in friedreich ataxia","volume":"35","author":"Greene","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"45","key":"10.1016\/j.leukres.2025.108112_bib24","doi-asserted-by":"crossref","first-page":"16345","DOI":"10.1073\/pnas.0508085102","article-title":"Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.leukres.2025.108112_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ejhg.2010.187","article-title":"Tumour-specific methylation of PTPRG intron 1 locus in sporadic and lynch syndrome colorectal cancer","volume":"19","author":"Roon","year":"2011","journal-title":"Eur. J. Hum. Genet"},{"issue":"6","key":"10.1016\/j.leukres.2025.108112_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.leukres.2009.10.018","article-title":"ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in b chronic lymphocytic leukemia","volume":"34","author":"Chantepie","year":"2010","journal-title":"Leuk. Res"},{"issue":"6","key":"10.1016\/j.leukres.2025.108112_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/leu.2008.397","article-title":"The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells","volume":"23","author":"Flotho","year":"2009","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.leukres.2025.108112_bib28","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.leukres.2025.108112_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinforma."},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"Edger: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13059-019-1727-y","article-title":"Performance of neural network basecalling tools for Oxford nanopore sequencing","volume":"20","author":"Wick","year":"2019","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.leukres.2025.108112_bib33","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","article-title":"Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications","volume":"27","author":"Krueger","year":"2011","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.leukres.2025.108112_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-10-r87","article-title":"Methylkit: a comprehensive r package for the analysis of genome-wide DNA methylation profiles","volume":"13","author":"Akalin","year":"2012","journal-title":"Genome Biol."},{"issue":"D1","key":"10.1016\/j.leukres.2025.108112_bib35","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","article-title":"BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis","volume":"44","author":"Bagger","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"10.1016\/j.leukres.2025.108112_bib36","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1182\/blood-2011-11-382226","article-title":"RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia","volume":"119","author":"Aimiuwu","year":"2012","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.leukres.2025.108112_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70078","article-title":"RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes","volume":"28","author":"Gulei","year":"2024","journal-title":"J. Cell Mol. Med"},{"issue":"11","key":"10.1016\/j.leukres.2025.108112_bib38","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/bloodadvances.2021005859","article-title":"TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms","volume":"6","author":"Schimmer","year":"2022","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib39","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.leukres.2025.108112_bib40","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1093\/nar\/29.13.e65","article-title":"A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters","volume":"29","author":"Clark","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.leukres.2025.108112_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10038-005-0235-y","article-title":"Abrogation of DUSP6 by hypermethylation in human pancreatic cancer","volume":"50","author":"Xu","year":"2005","journal-title":"J. Hum. Genet"},{"issue":"11","key":"10.1016\/j.leukres.2025.108112_bib42","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1541-7786.MCR-19-0747","article-title":"Intron 1-Mediated regulation of EGFR expression in EGFR-Dependent malignancies is mediated by AP-1 and BET proteins","volume":"17","author":"Jameson","year":"2019","journal-title":"Mol. Cancer Res"},{"issue":"13","key":"10.1016\/j.leukres.2025.108112_bib43","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2009-02-203547","article-title":"Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies","volume":"114","author":"Fandy","year":"2009","journal-title":"Blood"},{"issue":"D1","key":"10.1016\/j.leukres.2025.108112_bib44","doi-asserted-by":"crossref","first-page":"D1365","DOI":"10.1093\/nar\/gkaa882","article-title":"Project score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets","volume":"49","author":"Dwane","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2025.108112_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122696","article-title":"Who is who within the universe of TREM-like transcripts (TREML)?","volume":"348","author":"Ertel","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.leukres.2025.108112_bib46","article-title":"Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.leukres.2025.108112_bib47","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/JIR.S401566","article-title":"FLI1 regulates histamine decarboxylase expression to control inflammation signaling and leukemia progression","volume":"16","author":"Hu","year":"2023","journal-title":"J. Inflamm. Res"},{"issue":"6","key":"10.1016\/j.leukres.2025.108112_bib48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.stem.2017.11.003","article-title":"Bone marrow myeloid cells regulate Myeloid-Biased hematopoietic stem cells via a Histamine-Dependent feedback loop","volume":"21","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.leukres.2025.108112_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12964-022-00984-3","article-title":"MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer","volume":"20","author":"Wen","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.leukres.2025.108112_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116256","article-title":"MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT\/mTOR pathway","volume":"225","author":"Wen","year":"2024","journal-title":"Biochem Pharm."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:25:45Z","timestamp":1773127545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625006022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0145212625006022"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108112","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genes with altered expression by 5-Aza treatment in myeloid leukemia cells through methylation in intron 1","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108112"}}